scispace - formally typeset
G

Guy A. Rouleau

Researcher at Montreal Neurological Institute and Hospital

Publications -  935
Citations -  75050

Guy A. Rouleau is an academic researcher from Montreal Neurological Institute and Hospital. The author has contributed to research in topics: Gene & Genome-wide association study. The author has an hindex of 129, co-authored 884 publications receiving 65892 citations. Previous affiliations of Guy A. Rouleau include Utrecht University & University of Helsinki.

Papers
More filters
Journal ArticleDOI

Genetic and Epidemiological Study of Adult Ataxia and Spastic Paraplegia in Eastern Quebec.

TL;DR: The minimum prevalence of hereditary ataxias and spastic paraplegias in Eastern Quebec was estimated at 6.47/100 000 [95% CI; 6.44-6.51] with a 95% confidence interval (CI) as mentioned in this paper.
Posted ContentDOI

A comprehensive analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder

TL;DR: The results do not support a major role for variants in PRKN, PARK7, PINK1, VPS13C, ATP13A2, FBXO7, PLA2G6, LRRK2, GCH1 and VPS35 in the risk of iRBD.
Posted ContentDOI

Genome-wide association study of REM sleep behavior disorder identifies novel loci with distinct polygenic and brain expression effects

Lynne Krohn, +69 more
- 13 Sep 2021 - 
TL;DR: This paper performed the first genome-wide analyses on RBD, including genomewide association study, pathway analysis, heritability, genetic correlation, and mendelian randomization, and reported two novel RBD risk loci and replicate three previously reported, and identified key genetic similarities and differences between RBD and other synucleinopathies.
Journal ArticleDOI

Reversibility and Therapeutic Development for Neurodevelopmental Disorders, Insights from Genetic Animal Models.

TL;DR: A review of recent neurobiological advances from experimental models of NDDs can be found in this article , where the expanding property of cutting-edge technologies, such as gene editing and AAV-mediated gene delivery, are leveraged in animal models for the therapeutic development of NDFs.